Quadrant Capital Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,703
| Closed | -$89.7K | – | 1911 |
|
|
2025
Q1 | $89.7K | Buy |
2,703
+2,395
| +778% | +$79.5K | ﹤0.01% | 1555 |
|
|
2024
Q4 | $10.6K | Sell |
308
-74
| -19% | -$2.55K | ﹤0.01% | 2108 |
|
|
2024
Q3 | $15.3K | Hold |
382
| – | – | ﹤0.01% | 2003 |
|
|
2024
Q2 | $11.5K | Sell |
382
-70
| -15% | -$2.11K | ﹤0.01% | 2071 |
|
|
2024
Q1 | $15.2K | Sell |
452
-570
| -56% | -$19.1K | ﹤0.01% | 1951 |
|
|
2023
Q4 | $33K | Buy |
1,022
+329
| +47% | +$10.6K | ﹤0.01% | 1585 |
|
|
2023
Q3 | $22.7K | Sell |
693
-16
| -2% | -$524 | ﹤0.01% | 1653 |
|
|
2023
Q2 | $25K | Buy |
+709
| New | +$25K | ﹤0.01% | 1606 |
|
|
2023
Q1 | – | Sell |
-286
| Closed | -$15.8K | – | 2752 |
|
|
2022
Q4 | $15.8K | Buy |
286
+194
| +211% | +$10.7K | ﹤0.01% | 1761 |
|
|
2022
Q3 | $4K | Hold |
92
| – | – | ﹤0.01% | 2208 |
|
|
2022
Q2 | $4K | Buy |
+92
| New | +$4K | ﹤0.01% | 2037 |
|